JPH06298806A - Novel branched cyclodextrin and method for producing the same - Google Patents
Novel branched cyclodextrin and method for producing the sameInfo
- Publication number
- JPH06298806A JPH06298806A JP10596893A JP10596893A JPH06298806A JP H06298806 A JPH06298806 A JP H06298806A JP 10596893 A JP10596893 A JP 10596893A JP 10596893 A JP10596893 A JP 10596893A JP H06298806 A JPH06298806 A JP H06298806A
- Authority
- JP
- Japan
- Prior art keywords
- galactosyl
- group
- cyclodextrin
- hydroxyl group
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000858 Cyclodextrin Polymers 0.000 title claims abstract description 15
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 claims abstract description 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 22
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 20
- 235000000346 sugar Nutrition 0.000 claims abstract description 14
- -1 α-galactosyl Chemical group 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 125000003147 glycosyl group Chemical group 0.000 abstract description 3
- 102000004357 Transferases Human genes 0.000 abstract description 2
- 108090000992 Transferases Proteins 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 35
- 238000004458 analytical method Methods 0.000 description 13
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 241000533293 Sesbania emerus Species 0.000 description 8
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000012295 chemical reaction liquid Substances 0.000 description 6
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 5
- 229930182830 galactose Natural products 0.000 description 5
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 4
- 238000012916 structural analysis Methods 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 102000005840 alpha-Galactosidase Human genes 0.000 description 3
- 108010030291 alpha-Galactosidase Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000006276 transfer reaction Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004738 parenchymal cell Anatomy 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
(57)【要約】
【構成】 シクロデキストリンのグルコシル基の2位ま
たは3位水酸基にα結合でガラクトシル基が結合してい
る新規ガラクトシル−シクロデキストリン並びにシクロ
デキストリンとα−ガラクトシル糖化合物を含有する溶
液に、α−ガラクトシル基転移酵素を作用させることを
特徴とするシクロデキストリンのグルコシル基の2位ま
たは3位水酸基にα結合でガラクトシル基が結合してい
る新規ガラクトシル−シクロデキストリンの製造方法。
【効果】 本発明によれば、α−ガラクトシル基転移酵
素の糖転移作用を利用して、CD分子中のグルコシル基
の2級水酸基、すなわち2位または3位水酸基にα結合
でガラクトシル基が結合している新規な分岐CDを効率
よく得ることができる。本発明の新規な分岐CDは、医
薬品分野のほか食品分野,化粧品分野等における幅広い
利用が期待される。
(57) [Summary] [Structure] A novel galactosyl-cyclodextrin in which a galactosyl group is bonded to the 2- or 3-position hydroxyl group of the glucosyl group of cyclodextrin by an α bond, and a solution containing cyclodextrin and an α-galactosyl sugar compound A method for producing a novel galactosyl-cyclodextrin in which a galactosyl group is bonded to the 2- or 3-position hydroxyl group of the glucosyl group of cyclodextrin by an α bond, characterized by allowing α-galactosyl transferase to act on. According to the present invention, the galactosyl group is bound to the secondary hydroxyl group of the glucosyl group in the CD molecule, that is, the 2- or 3-position hydroxyl group by an α bond by utilizing the glycosyl transfer action of α-galactosyltransferase. It is possible to efficiently obtain the new branched CD. The novel branched CD of the present invention is expected to be widely used in the fields of foods, cosmetics, etc. in addition to the fields of medicines.
Description
【0001】[0001]
【産業上の利用分野】本発明は、新規な分岐シクロデキ
ストリンおよびその製造方法に関し、詳しくはシクロデ
キストリンのグルコシル基の2級水酸基、すなわち2位
または3位水酸基にα結合でガラクトシル基を結合させ
た新規ガラクトシル−シクロデキストリンおよび酵素の
糖転移作用を利用した該新規ガラクトシル−シクロデキ
ストリンの製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel branched cyclodextrin and a method for producing the same. The present invention also relates to a novel galactosyl-cyclodextrin and a method for producing the novel galactosyl-cyclodextrin utilizing the glycosyl transfer activity of an enzyme.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】シク
ロデキストリン(以下、CDと略記する。)は、グルコ
ースがα−1,4結合で連なった環状デキストリンで、
グルコース6,7,8個より成るそれぞれα−,β−お
よびγ−CDが良く知られている。最近ではCDの溶解
度を改善するため、これらCDにα−1,6結合でグル
コシル基やマルトシル基を結合させた分岐CDが合成さ
れている。BACKGROUND OF THE INVENTION Cyclodextrin (hereinafter abbreviated as CD) is a cyclic dextrin in which glucose is linked by α-1,4 bonds.
The α-, β-, and γ-CDs consisting of 6, 7 and 8 glucoses are well known. Recently, in order to improve the solubility of CD, branched CDs in which a glucosyl group or a maltosyl group is bonded to these CDs by α-1,6 bonds have been synthesized.
【0003】これらCDおよび分岐CDには分子内部に
空洞があり、しかもこの空洞内部が疏水性になっている
ため、包接作用があり、各種油性物質を取り込む性質を
有している。CDおよび分岐CDは、このような性質を
もっているため、食品工業,化粧品工業,医薬品工業な
どの分野で広く使用されている。These CDs and branched CDs have cavities inside the molecules, and since the insides of the cavities are made hydrophobic, they have an inclusion effect and have the property of incorporating various oily substances. CDs and branched CDs have such properties and are therefore widely used in the fields of food industry, cosmetics industry, pharmaceutical industry, and the like.
【0004】最近、医薬品工業の分野では、薬剤の副作
用を少なくするため、糖質の細胞認識性に着目して、こ
れをドラッグ・デリバリー・システムの薬剤運搬体の標
識細胞へのセンサーとして利用する研究が活発に行われ
ている。特に、ガラクトースは肝臓組織に、マンノース
は肝臓実質細胞,肝臓非実質細胞,マクロファージに強
い親和性を示すことが良く知られている。Recently, in the field of the pharmaceutical industry, in order to reduce side effects of drugs, attention is paid to the cell recognizability of sugars, and this is used as a sensor for labeled cells of drug carriers of drug delivery systems. Research is actively conducted. In particular, it is well known that galactose has a strong affinity for liver tissue and mannose has a strong affinity for liver parenchymal cells, non-parenchymal cells, and macrophages.
【0005】以前、我々は上述した現状に鑑み、分岐シ
クロデキストリンの側鎖のグルコシル基にガラクトシル
基またはマンノシル基が結合しているガラクトシル−分
岐CD,マンノシル−分岐CDの開発、およびCDのグ
ルコシル基の6位水酸基にガラクトシル基またはマンノ
シル基が結合しているガラクトシル−CD,マンノシル
−CDの開発に成功している。Previously, in view of the above-mentioned situation, we have developed a galactosyl-branched CD or a mannosyl-branched CD in which a galactosyl group or a mannosyl group is bonded to a glucosyl group of a branched cyclodextrin side chain, and a glucosyl group of CD. Have succeeded in developing galactosyl-CD and mannosyl-CD in which a galactosyl group or a mannosyl group is bonded to the 6-position hydroxyl group of the above.
【0006】そこで、本発明者らはCDの有する包接作
用とガラクトースのこの特質を利用して、ドラッグ・デ
リバリー・システムに応用することを目的として、CD
環のグルコシル基の2級水酸基、すなわち2位または3
位水酸基に直接ガラクトシル基を転移結合させたガラク
トシル−CDの合成を試みた。その結果、市販のα−ガ
ラクトシル基転移酵素がα−ガラクトシル糖化合物から
α−,β−およびγ−CDのグルコシル基の2級水酸基
にα結合でガラクトシル基を転移結合させたガラクトシ
ル−CDを合成することを見出した。特に、このうち未
熟コーヒー豆由来のα−ガラクトシル基転移酵素は、α
−,β−およびγ−CDのグルコシル基の2級水酸基に
α結合でガラクトシル基を転移結合させたガラクトシル
−CDを効率よく合成することを見出した。[0006] Therefore, the present inventors utilize the inclusion property of CD and this characteristic of galactose to apply it to a drug delivery system.
Secondary hydroxyl group of glucosyl group of ring, ie 2- or 3-position
An attempt was made to synthesize galactosyl-CD in which a galactosyl group was directly bonded to a hydroxyl group at a position. As a result, a commercially available α-galactosyltransferase synthesizes a galactosyl-CD from an α-galactosyl sugar compound by transferring the galactosyl group to the secondary hydroxyl group of the glucosyl group of α-, β- and γ-CD by α bond. I found that Among these, α-galactosyltransferase derived from unripe coffee beans is
It has been found that galactosyl-CD in which a galactosyl group is transfer-bonded to the secondary hydroxyl groups of glucosyl groups of −, β- and γ-CD by an α bond is efficiently synthesized.
【0007】[0007]
【課題を解決するための手段】すなわち、本発明はCD
のグルコシル基の2位または3位水酸基にα結合でガラ
クトシル基が結合している新規ガラクトシル−CD、並
びにCDとα−ガラクトシル糖化合物を含有する溶液
に、α−ガラクトシル基転移酵素を作用させることを特
徴とするCDのグルコシル基の2位または3位水酸基に
α結合でガラクトシル基が結合している新規ガラクトシ
ル−CDの製造方法を提供するものである。That is, the present invention is a CD
Of a novel galactosyl-CD in which a galactosyl group is bound to the 2- or 3-position hydroxyl group of the glucosyl group of α-galactosyl group and a solution containing CD and an α-galactosyl sugar compound with α-galactosyltransferase The present invention provides a method for producing a novel galactosyl-CD in which the galactosyl group is bonded to the 2- or 3-position hydroxyl group of the glucosyl group of CD by α bond.
【0008】本発明に係る新規分岐CDは、図1に示す
構造式I〜III で表すことができる。The novel branched CD according to the present invention can be represented by structural formulas I to III shown in FIG.
【0009】本発明の新規な分岐CDは、CDとα−ガ
ラクトシル糖化合物を含有する溶液に、α−ガラクトシ
ル基転移酵素を作用させることによって得られる。本発
明において、CDとしてはα−CD,β−CDおよびγ
−CDおよびこれらの分岐CDのいずれでもよく、また
これらの混合物であってもよい。The novel branched CD of the present invention can be obtained by allowing an α-galactosyltransferase to act on a solution containing CD and an α-galactosyl sugar compound. In the present invention, CD includes α-CD, β-CD and γ.
-CD and any of these branched CDs, or a mixture thereof.
【0010】本発明に用いるα−ガラクトシル糖化合物
(以下、糖供与体と記す。)としては、例えばメリビオ
ース,ラフィノース,フェニル−α−ガラクトシド,パ
ラニトロフェニル−α−ガラクトシド,α−ガラクトオ
リゴ糖などのα−ガラクトシル基を含む配糖体やオリゴ
糖あるいは多糖やその部分分解物およびそれらの混合物
なども用いることができる。The α-galactosyl sugar compound (hereinafter referred to as a sugar donor) used in the present invention includes, for example, melibiose, raffinose, phenyl-α-galactoside, paranitrophenyl-α-galactoside, α-galactooligosaccharide and the like. Glycosides containing α-galactosyl groups, oligosaccharides or polysaccharides, partial degradation products thereof, and mixtures thereof can also be used.
【0011】本発明に用いるα−ガラクトシル基転移酵
素としては、α−ガラクトシル糖化合物とCDを含有す
る溶液に作用させたとき、糖供与体を分解し、そのα−
ガラクトシル基をCDのグルコシル基の2級水酸基にα
結合で転移させ、α−ガラクトシル−CDを合成するも
のであれば、いずれも使用可能である。The α-galactosyltransferase used in the present invention decomposes a sugar donor when it is allowed to act on a solution containing an α-galactosyl sugar compound and CD, and its α-
The galactosyl group is converted to the secondary hydroxyl group of the glucosyl group of CD α
Any compound can be used as long as it is transferred by binding to synthesize α-galactosyl-CD.
【0012】本発明に用いるα−ガラクトシル基転移酵
素は、自然界に広く分布しているものである。例えば、
未熟コーヒー豆のような植物由来の酵素、アスペルギル
ス・ニガー,エスヘリチヤ・コリ,モルティエレラ・ヴ
ィナセなどの微生物由来の酵素がよく知られている。The α-galactosyltransferase used in the present invention is widely distributed in nature. For example,
Enzymes derived from plants such as unripe coffee beans, and enzymes derived from microorganisms such as Aspergillus niger, Escherichia coli, and Mortierella vinase are well known.
【0013】本発明の反応系において、CDと糖供与体
を含む溶液(水溶液または懸濁液)は、CDの濃度が約
1〜50%(W/W)、糖供与体の濃度が約1〜90%
(W/W)であることが望ましく、かつCDに対する糖
供与体の比率(重量)は、使用する糖供与体の種類によ
って異なるが、0.1〜50倍の範囲、好ましくは0.3〜
2倍の範囲とするのが適当である。また、水と親水性有
機溶媒、例えばジメチルスルホキサイド,メタノール,
アセトン等との混合液も使用可能である。In the reaction system of the present invention, the solution (aqueous solution or suspension) containing CD and the sugar donor has a CD concentration of about 1 to 50% (W / W) and a sugar donor concentration of about 1%. ~ 90%
(W / W) is desirable, and the ratio (weight) of sugar donor to CD varies depending on the type of sugar donor used, but is in the range of 0.1 to 50 times, preferably 0.3 to
It is suitable to set the range twice. Also, water and hydrophilic organic solvents such as dimethyl sulfoxide, methanol,
A mixed solution with acetone or the like can also be used.
【0014】反応液のpHは3〜10、好ましくは4〜
9、温度は20〜70℃、好ましくは30〜60℃に調
整して反応させることが適当である。使用酵素量は反応
時間と密接な関係があるので、通常は反応が5〜100
時間、好ましくは5〜20時間で終了するような酵素量
とすればよいが、これらに限定されるものではない。The pH of the reaction solution is 3 to 10, preferably 4 to
9. The temperature is adjusted to 20 to 70 ° C., preferably 30 to 60 ° C., and the reaction is appropriately performed. Since the amount of enzyme used is closely related to the reaction time, the reaction is usually 5-100.
The amount of enzyme may be such that it is completed in a time, preferably 5 to 20 hours, but the amount is not limited thereto.
【0015】以上のような方法で反応させて得られた液
を、高速液体クロマトグラフィーにかけて、CDへの転
移生成物を分画・分取した後、酵素分解法,FAB−M
Sによる分子量測定および核磁気共鳴法(NMR)によ
り構造解析を行った結果、図1に示す構造式I〜III で
表される分岐CDであることを確認した。The liquid obtained by reacting by the above method is subjected to high performance liquid chromatography to fractionate and collect transfer products to CD, and then to enzymatic decomposition method, FAB-M.
As a result of molecular weight measurement by S and structural analysis by nuclear magnetic resonance (NMR), it was confirmed to be a branched CD represented by Structural Formulas I to III shown in FIG.
【0016】[0016]
【実施例】次に、実施例により本発明を具体的に説明す
るが、本発明はこれらに限定されるものではない。 実施例1 (1)転移反応 メリビオース1g,α−CD0.5gを0.4mlのジメチ
ルスルホキサイドを含む50mM酢酸緩衝液(pH6.
5)4.0mlに溶解させた後、未熟コーヒー豆のα−ガ
ラクトシル基転移酵素(シグマ社製)を16単位加え、
40℃にて48時間反応させた。反応液の一部を高速液
体クロマトグラフィーにより分析した結果を図2に示
す。EXAMPLES Next, the present invention will be specifically described by way of examples, but the present invention is not limited to these. Example 1 (1) Transfer Reaction 1 g of melibiose and 0.5 g of α-CD were added to 0.4 ml of a 50 mM acetate buffer (pH 6.
5) After being dissolved in 4.0 ml, 16 units of unripe coffee bean α-galactosyltransferase (manufactured by Sigma) was added,
The reaction was carried out at 40 ° C for 48 hours. The result of having analyzed a part of reaction liquid by a high performance liquid chromatography is shown in FIG.
【0017】反応終了後、酵素を熱失活させた溶液をア
ミノ系のカラムを用いた高速液体クロマトグラフィーに
かけて転移生成物Aを分取した。単離した転移生成物A
をODS系のカラムを用いた高速液体クロマトグラフィ
ーにて分析したところ、2つのピークに分離し(図
3)、それぞれを単離した結果、転移生成物A1が13
7mg、転移生成物A2が8mg得られた。After the reaction was completed, the solution in which the enzyme was inactivated by heat was subjected to high performance liquid chromatography using an amino column to separate the transfer product A. Isolated transfer product A
Was analyzed by high performance liquid chromatography using an ODS-based column, and it was separated into two peaks (Fig. 3). As a result, each of the transfer products A1 was 13
7 mg and 8 mg of transfer product A2 were obtained.
【0018】(2)構造解析 上記(1)で単離された転移生成物A1は、FAB−M
S分析および13C−NMR解析により、本発明者が先に
見出したα−CDのCD環内のグルコシル基の6位水酸
基に1分子のガラクトシル基がα結合した構造であるこ
とが分かった(特願平4−114304号明細書)。ま
た、転移生成物A2は、FAB−MS分析により、分子
量は1135であることが分かった(図4)。(2) Structural analysis The transfer product A1 isolated in the above (1) is FAB-M.
From the S analysis and 13 C-NMR analysis, it was found that the present invention has a structure in which one molecule of a galactosyl group is α-bonded to the 6-position hydroxyl group of the glucosyl group in the CD ring of α-CD previously found by the present inventor ( Japanese Patent Application No. 4-114304). Further, the transfer product A2 was found to have a molecular weight of 1135 by FAB-MS analysis (FIG. 4).
【0019】また、図5に示すように、未熟コーヒー豆
のα−ガラクトシダーゼにより、完全に等モルのガラク
トースとα−CDに分解された。これらのことより、転
移生成物A2はα−CDに1分子のガラクトシル基がα
結合したものであることが分かった。さらに、転移生成
物A2は、ODS系のカラムを用いた高速液体クロマト
グラフィーの分析より、転移生成物A1とはリテンショ
ンタイムが異なることから、α−CDのCD環内のグル
コシル基の2位または3位水酸基に1分子のガラクトシ
ル基がα結合した構造であることが分かった。Further, as shown in FIG. 5, it was completely decomposed into unequal molar amounts of galactose and α-CD by α-galactosidase of unripe coffee beans. From these, the transfer product A2 has one molecule of galactosyl group in α-CD.
It turned out to be a combination. Furthermore, since the transfer product A2 has a retention time different from that of the transfer product A1 according to the analysis by high performance liquid chromatography using an ODS-based column, the 2-position of the glucosyl group in the CD ring of α-CD or It was found that one molecule of galactosyl group was α-bonded to the 3-position hydroxyl group.
【0020】実施例2 (1)転移反応 メリビオース1g,β−CD0.4gを0.4mlのジメチ
ルスルホキサイドを含む50mM酢酸緩衝液(pH6.
5)4.0mlに溶解させた後、未熟コーヒー豆のα−ガ
ラクトシル基転移酵素(シグマ社製)を16単位加え、
40℃にて48時間反応させた。反応液の一部を高速液
体クロマトグラフィーにより分析した結果を図6に示
す。Example 2 (1) Transfer Reaction 1 g of melibiose and 0.4 g of β-CD were added to a 50 mM acetate buffer solution (pH 6.4) containing 0.4 ml of dimethyl sulfoxide.
5) After being dissolved in 4.0 ml, 16 units of unripe coffee bean α-galactosyltransferase (manufactured by Sigma) was added,
The reaction was carried out at 40 ° C for 48 hours. The result of having analyzed a part of reaction liquid by a high performance liquid chromatography is shown in FIG.
【0021】反応終了後、酵素を熱失活させた溶液をア
ミノ系のカラムを用いた高速液体クロマトグラフィーに
かけて転移生成物Bを分取した。単離した転移生成物B
をODS系のカラムを用いた高速液体クロマトグラフィ
ーにて分析したところ、2つのピークに分離し(図
7)、それぞれを単離した結果、転移生成物B1が10
5mg、転移生成物B2が6mg得られた。After the completion of the reaction, the heat-inactivated solution of the enzyme was subjected to high performance liquid chromatography using an amino column to fractionate the transfer product B. Isolated transfer product B
Was analyzed by high performance liquid chromatography using an ODS-based column, and it was separated into two peaks (Fig. 7). As a result, each of the transfer products B1 was 10
5 mg and 6 mg of the transfer product B2 were obtained.
【0022】(2)構造解析 上記(1)で単離された転移生成物B1は、FAB−M
S分析および13C−NMR解析により、本発明者が先に
見出したβ−CDのCD環内のグルコシル基の6位水酸
基に1分子のガラクトシル基がα結合した構造であるこ
とが分かった(特願平4−114304号明細書)。ま
た、転移生成物B2は、FAB−MS分析により、分子
量は1297であることが分かった。(2) Structural analysis The transfer product B1 isolated in the above (1) is FAB-M.
From the S analysis and 13 C-NMR analysis, it was found that the present invention has a structure in which one molecule of a galactosyl group is α-bonded to the 6-position hydroxyl group of the glucosyl group in the CD ring of β-CD previously found by the present inventor ( Japanese Patent Application No. 4-114304). The transfer product B2 was found to have a molecular weight of 1297 by FAB-MS analysis.
【0023】また、図8に示すように、未熟コーヒー豆
のα−ガラクトシダーゼにより、完全に等モルのガラク
トースとβ−CDに分解された。これらのことより、転
移生成物B2はβ−CDに1分子のガラクトシル基がα
結合したものであることが分かった。さらに、転移生成
物B2は、ODS系のカラムを用いた高速液体クロマト
グラフィーの分析より、転移生成物B1とはリテンショ
ンタイムが異なることから、β−CDのCD環内のグル
コシル基の2位または3位水酸基に1分子のガラクトシ
ル基がα結合した構造であることが分かった。Further, as shown in FIG. 8, it was completely decomposed into unequal molar amounts of galactose and β-CD by α-galactosidase of unripe coffee beans. From these results, the transfer product B2 has one molecule of galactosyl group in α-CD with α
It turned out to be a combination. Furthermore, the transfer product B2 has a retention time different from that of the transfer product B1 according to an analysis by high performance liquid chromatography using an ODS-based column, and therefore, the 2-position of the glucosyl group in the CD ring of β-CD or It was found that one molecule of galactosyl group was α-bonded to the 3-position hydroxyl group.
【0024】実施例3 (1)転移反応 メリビオース1g,γ−CD0.5gを0.4mlのジメチ
ルスルホキサイドを含む50mM酢酸緩衝液(pH6.
5)4.0mlに溶解させた後、未熟コーヒー豆由来のα
−ガラクトシル基転移酵素(シグマ社製)を16単位加
え、40℃にて48時間反応させた。反応液の一部を高
速液体クロマトグラフィーにより分析した結果を図9に
示す。Example 3 (1) Transfer Reaction 1 g of melibiose and 0.5 g of γ-CD were added to a 50 mM acetate buffer solution (pH 6.4) containing 0.4 ml of dimethyl sulfoxide.
5) After dissolving in 4.0 ml, α derived from unripe coffee beans
-Galactosyl transferase (manufactured by Sigma) was added in 16 units and reacted at 40 ° C for 48 hours. The result of having analyzed a part of reaction liquid by a high performance liquid chromatography is shown in FIG.
【0025】反応終了後、酵素を熱失活させた溶液をア
ミノ系のカラムを用いた高速液体クロマトグラフィーに
かけて転移生成物Cを分取した。単離した転移生成物C
をODS系のカラムを用いた高速液体クロマトグラフィ
ーにて分析したところ、2つのピークを分離し(図1
0)、それぞれを単離した結果、転移生成物C1が14
6mg、転移生成物C2が9mg得られた。After the reaction was completed, the solution in which the enzyme was inactivated by heat was subjected to high performance liquid chromatography using an amino column to fractionate the transfer product C. Isolated transfer product C
Was analyzed by high performance liquid chromatography using an ODS column, and two peaks were separated (Fig. 1
0), the isolation of each resulted in the transfer product C1 being 14
6 mg and 9 mg of the transfer product C2 were obtained.
【0026】(2)構造解析 上記(1)で単離された転移生成物C1は、FAB−M
S分析および13C−NMR解析により、本発明者が先に
見出したγ−CDのCD環内のグルコシル基の6位水酸
基に1分子のガラクトシル基がα結合した構造であるこ
とが分かった(特願平4−114304号明細書)。ま
た、転移生成物C2は、FAB−MS分析により、分子
量は1459であることが分かった。(2) Structural analysis The transfer product C1 isolated in the above (1) is FAB-M.
From the S analysis and 13 C-NMR analysis, it was found that the present invention has a structure in which one molecule of a galactosyl group is α-bonded to the 6-position hydroxyl group of the glucosyl group in the CD ring of γ-CD found by the present inventor ( Japanese Patent Application No. 4-114304). The transfer product C2 was found to have a molecular weight of 1459 by FAB-MS analysis.
【0027】また、図11に示すように、未熟コーヒー
豆のα−ガラクトシダーゼにより、完全に等モルのガラ
クトースとγ−CDに分解された。これらのことより、
転移生成物C2はγ−CDに1分子のガラクトシル基が
α結合したものであることが分かった。さらに、転移生
成物C2は、ODS系のカラムを用いた高速液体クロマ
トグラフィーの分析より、転移生成物C1とはリテンシ
ョンタイムが異なることから、γ−CDのCD環内のグ
ルコシル基の2位または3位水酸基に1分子のガラクト
シル基がα結合した構造であることが分かった。Further, as shown in FIG. 11, it was completely decomposed into unequal molar amounts of galactose and γ-CD by α-galactosidase of unripe coffee beans. Than these things,
It was found that the transfer product C2 was one in which one molecule of galactosyl group was α-bonded to γ-CD. Furthermore, the transfer product C2 has a retention time different from that of the transfer product C1 according to an analysis by high performance liquid chromatography using an ODS-based column. It was found that one molecule of galactosyl group was α-bonded to the 3-position hydroxyl group.
【0028】[0028]
【発明の効果】本発明によれば、α−ガラクトシル基転
移酵素の糖転移作用を利用して、CD分子中のグルコシ
ル基の2級水酸基、すなわち2位または3位水酸基にα
結合でガラクトシル基が結合している新規な分岐CDを
効率よく得ることができる。本発明の新規な分岐CD
は、医薬品分野のほか食品分野,化粧品分野等における
幅広い利用が期待される。INDUSTRIAL APPLICABILITY According to the present invention, by utilizing the glycosyl transfer activity of α-galactosyltransferase, α is attached to the secondary hydroxyl group of the glucosyl group in the CD molecule, that is, the 2- or 3-position hydroxyl group.
It is possible to efficiently obtain a novel branched CD having a galactosyl group bonded by the bond. Novel branched CD of the present invention
Is expected to be widely used in the fields of food, cosmetics, etc. in addition to the field of medicine.
【図1】 本発明により得られる分岐CDの構造を示
す。FIG. 1 shows the structure of a branched CD obtained according to the present invention.
【図2】 実施例1の反応液の高速液体クロマトグラム
である。2 is a high performance liquid chromatogram of the reaction liquid of Example 1. FIG.
【図3】 実施例1の転移生成物Aの高速液体クロマト
グラムである。FIG. 3 is a high performance liquid chromatogram of the transfer product A of Example 1.
【図4】 実施例1の転移生成物A2のFAB−MS分
析である。FIG. 4 is a FAB-MS analysis of the transfer product A2 of Example 1.
【図5】 実施例1の転移生成物A2の酵素分解液の高
速液体クロマトグラムである。5 is a high performance liquid chromatogram of the enzymatic decomposition solution of the transfer product A2 of Example 1. FIG.
【図6】 実施例2の反応液の高速液体クロマトグラム
である。FIG. 6 is a high performance liquid chromatogram of the reaction liquid of Example 2.
【図7】 実施例2の転移生成物Bの高速液体クロマト
グラムである。FIG. 7 is a high performance liquid chromatogram of the transfer product B of Example 2.
【図8】 実施例2の転移生成物B2の酵素分解液の高
速液体クロマトグラムである。FIG. 8 is a high performance liquid chromatogram of the enzymatic decomposition solution of the transfer product B2 of Example 2.
【図9】 実施例3の反応液の高速液体クロマトグラム
である。FIG. 9 is a high performance liquid chromatogram of the reaction liquid of Example 3.
【図10】 実施例3の転移生成物Cの高速液体クロマ
トグラムである。10 is a high performance liquid chromatogram of the transfer product C of Example 3. FIG.
【図11】 実施例3の転移生成物C2の酵素分解液の
高速液体クロマトグラムである。FIG. 11 is a high performance liquid chromatogram of the enzymatic decomposition solution of the transfer product C2 of Example 3.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 小泉 京子 大阪府藤井寺市春日丘3−14−3 (72)発明者 桑原 宣洋 神奈川県横浜市鶴見区大黒町13番46号 塩 水港精糖株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Kyoko Koizumi 3-14-3 Kasugaoka, Fujiidera City, Osaka Prefecture (72) Nobuhiro Kuwahara 13-46 Daikokucho, Tsurumi-ku, Yokohama-shi, Kanagawa Shimizu Port Sugar Co., Ltd. Within
Claims (2)
位または3位水酸基にα結合でガラクトシル基が結合し
ている新規ガラクトシル−シクロデキストリン。1. A glucosyl group of cyclodextrin of 2
A novel galactosyl-cyclodextrin in which a galactosyl group is bonded to the hydroxyl group at the 3-position or the 3-position by an α bond.
糖化合物を含有する溶液に、α−ガラクトシル基転移酵
素を作用させることを特徴とするシクロデキストリンの
グルコシル基の2位または3位水酸基にα結合でガラク
トシル基が結合している新規ガラクトシル−シクロデキ
ストリンの製造方法。2. A galactosyl by an α bond to the 2- or 3-position hydroxyl group of the glucosyl group of cyclodextrin, which is characterized in that an α-galactosyltransferase is allowed to act on a solution containing cyclodextrin and an α-galactosyl sugar compound. A method for producing a novel galactosyl-cyclodextrin having a group bonded thereto.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10596893A JP3552732B2 (en) | 1993-04-09 | 1993-04-09 | New branched cyclodextrin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10596893A JP3552732B2 (en) | 1993-04-09 | 1993-04-09 | New branched cyclodextrin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06298806A true JPH06298806A (en) | 1994-10-25 |
JP3552732B2 JP3552732B2 (en) | 2004-08-11 |
Family
ID=14421587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10596893A Expired - Fee Related JP3552732B2 (en) | 1993-04-09 | 1993-04-09 | New branched cyclodextrin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3552732B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007009265A1 (en) * | 2005-07-22 | 2007-01-25 | The Governors Of The University Of Alberta Tec Edmonton | NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS |
US7223570B2 (en) | 2001-03-09 | 2007-05-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Branched cyclic tetrasaccharide, process for producing the same, and use |
-
1993
- 1993-04-09 JP JP10596893A patent/JP3552732B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223570B2 (en) | 2001-03-09 | 2007-05-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Branched cyclic tetrasaccharide, process for producing the same, and use |
WO2007009265A1 (en) * | 2005-07-22 | 2007-01-25 | The Governors Of The University Of Alberta Tec Edmonton | NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS |
Also Published As
Publication number | Publication date |
---|---|
JP3552732B2 (en) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019021510A1 (en) | Method for producing flavonoid clathrate | |
JP3078923B2 (en) | Novel branched cyclodextrin and method for producing the same | |
JP3865436B2 (en) | Process for producing branched cyclodextrins | |
JP3552732B2 (en) | New branched cyclodextrin | |
JP3086076B2 (en) | New galactosyl-branched cyclodextrin | |
EP0565106B1 (en) | Method of preparing branched cyclodextrin | |
JP3122203B2 (en) | Novel heterobranched cyclodextrin and method for producing the same | |
JP2863262B2 (en) | Novel hetero-branched cyclodextrin in which a galactosyl group is transfer-bonded to the side chain portion of a branched cyclodextrin by an α-bond, and a method for producing the same | |
JP3816554B2 (en) | Novel branched cyclodextrin and method for producing the same | |
JP2863263B2 (en) | Novel hetero-branched cyclodextrin in which a galactosyl group is transfer-linked to the side chain part of a branched cyclodextrin by β-bond, and method for producing the same | |
JP3655325B2 (en) | Mannosyl-cyclodextrin | |
JP3637086B2 (en) | Mannosyl-cyclodextrin production method | |
JP3637085B2 (en) | Method for producing mannosyl-cyclodextrin | |
JP2700423B2 (en) | Glucosyl-cyclodextrin production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20040406 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Effective date: 20040427 Free format text: JAPANESE INTERMEDIATE CODE: A61 |
|
R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |